Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia–reperfusion injuryEvidence for a role of KATP channels

被引:0
|
作者
D. Johansen
K. Ytrehus
G. F. Baxter
机构
[1] The Royal Veterinary College,Department of Basic Sciences
[2] University of London,Department of Medical Physiology
[3] University of Tromsø,undefined
来源
关键词
hydrogen sulfide; ischemia–reperfusion; infarct size; K; channel;
D O I
暂无
中图分类号
学科分类号
摘要
Hydrogen sulfide (H2S) is a gaseous mediator, produced by the metabolic pathways that regulate tissue concentrations of sulfur–containing amino acids. Recent studies indicate that endogenous or exogenous H2S exerts physiological effects in the cardiovascular system of vertebrates, possibly through modulation of KATP channel opening. The present study was undertaken to examine the hypothesis that H2S is cytoprotective against myocardial ischemia–reperfusion injury and that this protective action is mediated by KATP opening. Rat isolated hearts were Langendorff–perfused and underwent 30 min left main coronary artery occlusion and 120 min reperfusion. The resulting injury was assessed as infarct size, determined by tetrazolium staining. Treatment of hearts with the H2S–donor, NaHS, commencing 10 min prior to the onset of coronary occlusion and maintained until 10 min reperfusion, resulted in a concentration–dependent limitation of infarct size (control, 41.0 ± 2.6% of risk zone; NaHS 0.1 μM, 33.9 ± 2.1%, [0.05 > P < 0.1]; NaHS 1 μM, 20.2 ± 2.1% [P < 0.01]). Pretreatment with the KATP channel blockers glibenclamide 10 μM or sodium 5–hydroxydecanoate (5HD) 100 μM led to abrogation of the infarct–limiting effect of NaHS 1 μM (glibenclamide + NaHS 42.5 ± 3.6%; 5HD + NaHS 44.7 ± 2.2%). No statistically significant effects of NaHS treatment on coronary flow, heart rate or left ventricular developed pressure were observed in this experimental preparation. These data provide the first evidence that exogenous H2S protects against irreversible ischemia–reperfusion injury in myocardium and support the involvement of KATP opening in the mechanism of action. Further work is required to elucidate the potential role of endogenous H2S as a cytoprotective mediator against myocardial ischemia–reperfusion injury, the mechanisms regulating its generation, and the nature of its interaction with protein targets such as the KATP channel.
引用
收藏
页码:53 / 60
页数:7
相关论文
共 50 条
  • [21] Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability
    Donnarumma, Erminia
    Ali, Murtuza J.
    Rushing, Amanda M.
    Scarborough, Amy L.
    Bradley, Jessica M.
    Organ, Chelsea L.
    Islam, Kazi N.
    Polhemus, David J.
    Evangelista, Stefano
    Cirino, Giuseppe
    Jenkins, J. Stephen
    Patel, Rajan A. G.
    Lefer, David J.
    Goodchild, Traci T.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (07): : 1 - 17
  • [22] The Role of the Signaling Pathways Involved in the Protective Effect of Exogenous Hydrogen Sulfide on Myocardial Ischemia-Reperfusion Injury
    Lv, Shuangyu
    Li, Xiaotian
    Zhao, Shizhen
    Liu, Huiyang
    Wang, Honggang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [23] Ischemic preconditioning decreases the reperfusion-related formation of hydroxyl radicals in a rabbit model of regional myocardial ischemia and reperfusion:: The role of KATP channels
    Raphael, J
    Drenger, B
    Rivo, J
    Berenshtein, E
    Chevion, M
    Gozal, Y
    FREE RADICAL RESEARCH, 2005, 39 (07) : 747 - 754
  • [24] Interaction between hydrogen sulfide (H2S) and nitric oxide (NO) during the process of myocardial ischemia in rats
    Chen, Chang Qing
    Wang, Yan Xia
    Zhu, Yi Chun
    Zhu, Yi Zhun
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 175 - 175
  • [25] Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide
    Salloum, Fadi N.
    Das, Anindita
    Samidurai, Arun
    Hoke, Nicholas N.
    Chau, Vinh Q.
    Ockaili, Ramzi A.
    Stasch, Johannes-Peter
    Kukreja, Rakesh C.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 302 (06): : H1347 - H1354
  • [26] Phosphorylation of BK channels modulates the sensitivity to hydrogen sulfide (H2S)
    Sitdikova, Guzel F.
    Fuchs, Roman
    Kainz, Verena
    Weiger, Thomas M.
    Hermann, Anton
    FRONTIERS IN PHYSIOLOGY, 2014, 5 : 431
  • [27] Mitochondria-targeted Hydrogen Sulfide (H2S), but not Untargeted H2S, Reverses Ventricular Arrhythmia at Reperfusion
    Whiteman, Matthew
    Karwi, Qutuba G.
    Wood, Mark E.
    Baxter, Gary F.
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 112 : 124 - 125
  • [28] Gaseous Hydrogen Sulfide Protects against Myocardial Ischemia-Reperfusion Injury in Mice Partially Independent from Hypometabolism
    Snijder, Pauline M.
    de Boer, Rudolf A.
    Bos, Eelke M.
    van den Born, Joost C.
    Ruifrok, Willem-Peter T.
    Vreeswijk-Baudoin, Inge
    van Dijk, Marcory C. R. F.
    Hillebrands, Jan-Luuk
    Leuvenink, Henri G. D.
    van Goor, Harry
    PLOS ONE, 2013, 8 (05):
  • [29] A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury
    Sun, Xiaotian
    Wang, Wenshuo
    Dai, Jing
    Jin, Sheng
    Huang, Jiechun
    Guo, Changfa
    Wang, Chunsheng
    Pang, Liewen
    Wang, Yiqing
    SCIENTIFIC REPORTS, 2017, 7
  • [30] A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury
    Xiaotian Sun
    Wenshuo Wang
    Jing Dai
    Sheng Jin
    Jiechun Huang
    Changfa Guo
    Chunsheng Wang
    Liewen Pang
    Yiqing Wang
    Scientific Reports, 7